维普中文期刊产品整合服务
17篇 您的检索式:作者名="J Humblet"
    题名 作者 年代 出处 被引量
1Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial显示文摘Axel Grothey Eric Van Cutsem Alberto Sobrero Salvatore Siena Alfredo Falcone Marc Ychou Yves Humblet Olivier Bouché Laurent Mineur Carlo Barone Antoine Adenis Josep Tabernero Takayuki Yoshino Heinz-Josef Lenz Richard M Goldberg Daniel J Sargent Frank Ciho 2012The Lancet2012,,:10
2Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradial and cyproterone acetate anglucose and insulin metabolism显示文摘Scheen A J Jandrain B J Humblet D M 1993Fertil Steril1993,59,:1
3X-SITE:use of empirically derived atomic packing preferences to identify favourable interaction regions in the binding sites of proteins显示文摘 Thornton J M Humblet C 1996J Mol Biol1996,259,:1
4Effect of a 1-year treatment with a low dose combined oral contraceptive containing eithinyl estradial and cyproterone acetate anglucose and insulin metabolism显示文摘SCHEEN A J JANDRAIN B J HUMBLET D M 1993Fertil Steril1993,59,:1
5A randomized,double blind,placebo controlled multicenter phase III trial to evaluate the efficacy and safety of adding bevacizumab to erlo-tinib and gemcitabine in patients with metastatic pancreatic cancer显示文摘Vervenne W Bennouna J Humblet Y 2008J Clin Oncol2008,,:1
6A randomized, double-blind, placebo (P) controlled, muhicenter phase Ⅲ trial to evaluate the efficacy and safety ofaddingbevacizumab (B) to erlotinib (E) and gemcitabine (G) in patients (pts) with metastatic pancreatic cancer显示文摘Vervenne W Bennouna J Humblet Y 2008J Clin Oncol2008,,:1
7Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial显示文摘Jandrain B J Humblet DM Jaminet CB 1990Am J Obstet Gynecol1990,163,12:1
8K - matrix analysis of resonance nuclear reactions 显示文摘J Humblet B W Filippone S E Koonin 1991Phys Rev C1991,44,:1
9Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial显示文摘Axel Grothey Eric Van Cutsem Alberto Sobrero Salvatore Siena Alfredo Falcone Marc Ychou Yves Humblet Olivier Bouché Laurent Mineur Carlo Barone Antoine Adenis Josep Tabernero Takayuki Yoshino Heinz-Josef Lenz Richard M Goldberg Daniel J Sargent Frank Ciho 2012The Lancet2012,,:1
10Sur le moment d'impulsion d'une onde electromagnetique显示文摘Humblet J 1943Physica1943,10,7:1
11Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients显示文摘 Gerain J Humblet Y 2000Ann Hematol2000,79,:1
12A randomized, double-blind, placebo (P) controlled, muhicenter phase Ⅲ trial to evaluate the efficacy and safety of adding bevacizumab (B) to erlotinib (E) and gemcitabine (G) in patients (pts) with metastatic pancreatic cancer显示文摘Vervenne W Bennonna J Humblet Y 2008J Clin Oncol2008,,:1
13Environmental pol utants and breast cancer:Epidemiologic studies显示文摘Brody J G Moysich K B Humblet O 2007Cancer2007,109,12:1
14Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial显示文摘Axel Grothey Eric Van Cutsem Alberto Sobrero Salvatore Siena Alfredo Falcone Marc Ychou Yves Humblet Olivier Bouché Laurent Mineur Carlo Barone Antoine Adenis Josep Tabernero Takayuki Yoshino Heinz-Josef Lenz Richard M Goldberg Daniel J Sargent Frank Ciho 2012The Lancet2012,,:1
15A randomized,double-blind,placebo(P)controlled,multicenter phase III trial to evaluatethe efficacy and safety of adding bevacizumab(B)to erlotinib(E)andgemcitabine(G)in patients(pts)with metastatic pancreatic cancer显示文摘Vervenne W Bennouna J Humblet Y 2008J Clin Oncol2008,26,:1
16Meropenem versus ceftazidime as emp irical monotherapy for febrile neutropenic cancer patients显示文摘Vandercam B Gerain J Humblet Y Ann Hematol0,79,3:1
17A randomized, double-blind, placebo (P) controlled, multieenter Phase Ⅲ trial to evaluate the efficacy and safety of adding bevacizumab (B) to erltinib ( E ) and gemcitabine ( G ) in patients ( pts ) with metastatic pancreatic cancer显示文摘Vervenne V Bennouna J Humblet Y 2008J Clin Oncol2008,26,15:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费